S2B
SYN2BIO GPW LISTED

Shareholders

as of September 20, 2026 · source: notifications under Art. 69 of the Offering Act · 3 entities above 5%

FREE FLOAT
53.51%
4,670,430 shares
LARGEST STAKE
23.45%
Cezary Kozanecki
TOP 3 CONCENTRATION
46.49%
3 entities above 5%
LATEST CHANGE
May 19, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications · share count normalized to 8,729,129 shares outstanding
SHAREHOLDERS ≥5% 46.49% FREE FLOAT 53.51%
Cezary Kozanecki 23.45%
2,047,380 shares · notification September 19, 2026
Mariusz Książek 15.76%
1,376,143 shares · notification August 16, 2026
NATIONALE-NEDERLANDEN Powszechne Towarzystwo Emerytalne S.A. 7.28%
635,176 shares · notification August 16, 2026
Other 53.51%
4,670,430 shares · composition undisclosed

Notification history

crossings above/below the 5% / 10% / 20% thresholds
May 19, 2026
ESPI (wykaz z WZ) — baseline reading
MELHUS COMPANY LTD: new in the registry, 23.45%

Capital and votes

Number of shares
8,729,129
ISIN
PLSNBIO00013
Sector
Biotechnologia
Market
GPW
Country
PL
Listing date
April 01, 2026

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.